相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Educational delay and attainment in persons with neurofibromatosis 1 in Denmark
Karoline Doser et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2019)
A qualitative study of the impact of plexiform neurofibromas on need fulfilment in adults with neurofibromatosis type 1
Alice Heaney et al.
SAGE OPEN MEDICINE (2019)
Worries and needs of adults and parents of adults with neurofibromatosis type 1
Andre B. Rietman et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2018)
Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire
Rosalie E. Ferner et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2017)
Psychometric analysis of the Generalized Anxiety Disorder scale (GAD-7) in primary care using modern item response theory
Pascal Jordan et al.
PLOS ONE (2017)
The Role of Appearance in Adolescents' Experiences of Neurofibromatosis Type 1: A Survey of Young People and Parents
Jenny Barke et al.
JOURNAL OF GENETIC COUNSELING (2016)
Depression among adults with neurofibromatosis type 1: prevalence and impact on quality of life
J. S. Cohen et al.
CLINICAL GENETICS (2015)
Prevalence of depression, quality of life and antidepressant treatment in the Danish General Suburban Population Study
Christina Ellervik et al.
NORDIC JOURNAL OF PSYCHIATRY (2014)
Development of the Adult PedsQL™ Neurofibromatosis Type 1 Module: Initial Feasibility, Reliability and Validity
Kavitha Nutakki et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2013)
Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis
Alex J. Mitchell et al.
LANCET ONCOLOGY (2013)
Social functioning in adults with neurofibromatosis type 1
Natalie A. Pride et al.
RESEARCH IN DEVELOPMENTAL DISABILITIES (2013)
Neuropsychological profile in adults with neurofibromatosis type 1 compared to a control group
M. -J. Descheemaeker et al.
JOURNAL OF INTELLECTUAL DISABILITY RESEARCH (2013)
Psychological Burden in Adult Neurofibromatosis Type 1 Patients: Impact of Disease Visibility on Body Image
Sofia Granstroem et al.
DERMATOLOGY (2012)
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome
Daphne L. Wang et al.
GENETICS IN MEDICINE (2012)
Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989
D. Gareth R. Evans et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Mortality Associated with Neurofibromatosis 1: A Cohort Study of 1895 Patients in 1980-2006 in France
Tu Anh Duong et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
Impact of neurofibromatosis 1 upon quality of life in childhood: a cross-sectional study of 79 cases
P. Wolkenstein et al.
BRITISH JOURNAL OF DERMATOLOGY (2009)
Health-Related Quality of Life in Patients with Neurofibromatosis Type 1
Yllka Kodra et al.
DERMATOLOGY (2009)
Neurofibromatosis type 1
Kevin P. Boyd et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2009)
Validation and Standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the General Population
Bernd Löwe et al.
MEDICAL CARE (2009)
The PedsQL™ 4.0 Generic Core Scales Young Adult Version Feasibility, Reliability and Validity in a University Student Population
James W. Varni et al.
JOURNAL OF HEALTH PSYCHOLOGY (2009)
Impact of neurofibromatosis 1 on quality of life: A cross-sectional study of 176 American cases
Patricia Z. Page et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2006)
A brief measure for assessing generalized anxiety disorder -: The GAD-7
Robert L. Spitzer et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Neurofibromatosis type 1:: psychiatric disorders and quality of life impairment
R Belzeaux et al.
PRESSE MEDICALE (2006)
The nature and frequency of cognitive deficits in children with neurofibromatosis type 1
SL Hyman et al.
NEUROLOGY (2005)
Visibility of neurofibromatosis 1 and psychiatric morbidity
P Wolkenstein et al.
ARCHIVES OF DERMATOLOGY (2003)
The PHQ-9: A new depression diagnostic and severity measure
K Kroenke et al.
PSYCHIATRIC ANNALS (2002)
Quality-of-life impairment in neurofibromatosis type 1 -: A cross-sectional study of 128 cases
P Wolkenstein et al.
ARCHIVES OF DERMATOLOGY (2001)
The PHQ-9 - Validity of a brief depression severity measure
K Kroenke et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2001)
Mortality in neurofibromatosis 1: An analysis using US death certificates
SA Rasmussen et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
分享论文
